跳至主要内容
临床试验/NCT01332409
NCT01332409已完成不适用

Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2009年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
2,000
试验地点
1
主要终点
The incidence of adverse events in Japanese patients treated with salmeterol and fluticasone based on prescribing information under the conditions of general clinical practice.

研究概览

简要总结

To investigate possible problems or questions in safety and effectiveness of salmeterol and fluticasone in patients with chronic obstructive pulmonary disease (bronchitis chronic / emphysema). In this special drug use investigation, onset of pneumonia shall be handled as the priority investigation item.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Must use salmeterol and fluticasone for the first time

排除标准

  • Patients with hypersensitivity to salmeterol and fluticasone
  • Patients with infection which salmeterol and fluticasone is not effective
  • Patients with deep mycosis

研究组 & 干预措施

Patients prescribed salmeterol and fluticasone

Patients with chronic obstructive pulmonary disease prescribed salmeterol and fluticasone during study period

干预措施: Salmeterol and Fluticasone (Drug)

结局指标

主要结局

The incidence of adverse events in Japanese patients treated with salmeterol and fluticasone based on prescribing information under the conditions of general clinical practice.

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Special Drug Use Investigation for ADOAIR DISKUS... | 临床试验